Objective:
To compare the ischemia modified albumin (IMA) levels in the serum and follicular fluid of infertile patients with polycystic ovary syndrome (PCOS), and without PCOS, and their IVF outcomes.
Material and Method:
We conducted a prospective cohort study with patients undergoing IVF treatment at Ege University IVF Center during 2021 and 2023. Blood and follicular fluid samples were collected from a total of 113 infertile women with PCOS (n = 56) and without PCOS (n = 57). The samples were centrifuged and stored at -80 0C at the Ege University Department of Biochemistry laboratories. The serum and follicular fluid IMA levels of these patients and their IVF outcomes were compared.
Results:
No statistically significant difference was found between the two groups when compared for mean age, body mass index (BMI) and duration of infertility (p = 0.075, 0.073 and 0.479 respectively). The IVF results showed statistically significant differences. Although the number of oocytes retrieved and number of embryos were higher in the PCOS group (p value < 0.001 and 0.013, respectively), the recombinant FSH dose used for ovulation induction was lower in PCOS group (p < 0.001) than non-PCOS group. Serum IMA levels in PCOS patients were found to be lower than the control group, but this difference was not statistically significant (p = 0.16). Follicular fluid IMA values were found to be lower in the PCOS group than the control group, while the difference was statistically significant (p = 0.031). Considering the pregnancy results, biochemical pregnancy, clinical pregnancy, and ongoing pregnancy rates in the non-PCOS group was higher than the PCOS group, although the difference was not statistically significant (p = 0.08, 0.29, 0.18 respectively).
Conclusion:
The results of studies comparing serum IMA values of PCOS and non-PCOS cases are conflicting. In our study, we found that the serum and follicular fluid IMA levels in non-PCOS group were higher than the PCOS group. Biochemical, clinical and ongoing pregnancy rates were found higher in the non-PCOS group when compared to the PCOS group.